Functional performance of upper limb and quality of life after sentinel lymph node biopsy of breast cancer;Desempenho funcional de membros superiores e qualidade de vida após biópsia de linfonodo sentinela para o tratamento do câncer de mama

Revista Brasileira de Fisioterapia

Volumn 15, Issue 2, 2011, Pages 146-153

  Velloso, Fernanda S B ^a   Barra, Alexandre A ^b   Dias, Rosângela C ^c  

^a CENTRO UNIVERSITÁRIO DE BELO HORIZONTE   (Brazil)

^b Hospital Governador Israel Pinheiro   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Breast cancer; Morbidity; Quality of life; Sentinel lymph node biopsy

Indexed keywords

EID: 79958016381     PISSN: 14133555     EISSN: 18099246     Source Type: Journal    
DOI: 10.1590/S1413-35552011000200010     Document Type: Article

References (42)

1. Kootstra J, Hoekstra-Weebers JEHM, Rietman H, de Vries J, Baas P, Geertzen JHB, et al. Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol. 2008;15(9):2533-2541.
2. Del Bianco P, Zavagno G, Burelli P, Scalso G, Barutta L, Carraro P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomized clinical trial. Eur J Surg Oncol. 2008;34(5):508-513.
3. Cardoso FR, Oliveira ALEAS. Avaliação postural em mulheres submetidas à mastectomia radical modificada: estudo de cinco casos. Revista Latinoamericana de Mastologia. 2004;5(1):13-8.
4. Veronesi U, Zurrida S. Present and future of sentinel node lymphadenectomy in breast cancer. Recent Results Cancer Res. 2000;157:221-227.
5. Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE. Long-term morbidity of sentinel node biopsy versus complete axillary dissection of unilateral breast cancer. Ann Surg Oncol. 2008;15(7):1996-2005.
6. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Feher MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245(3):452-461.
7. Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JHB, Robinson DPH, de Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26(2):78-84.
8. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002;9(8):745-753.
9. Pater J, Parulekar W. Sentinel lymph node biopsy in early breast cancer: has its time come? J Natl Cancer Inst. 2006;98(9):568-569.
10. Silberman AW, McVay C, Cohen JS, Altura JF, Brackert S, Sarna GP, et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg. 2004;240(1):1-6.
11. Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol. 2006;32(2):148-152.
12. Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E, Uzan S. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol. 2005;92(1):17-22.
13. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23(19):4312-4321.
14. Arnaud S, Houvenaeghel G, Moutardier V, Butarelli M, Martino M, Tallet A, et al. Patients' and surgeons' perspectives on axillary surgery for breast cancer. Eur J Surg Oncol. 2004;30(7):735-743.
15. Leidenius M, Leivonen M, Vironen J, Von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol. 2005;92(1):23-31.
16. Makluf ASD, Dias RC, Barra AA. Avaliação da qualidade de vida em mulheres com câcer de mama. Rev Bras Cancerol. 2006;52(1):49-58.
17. Belasco AGS, Sesso RCC. Qualidade de vida: princípios, focos de estudo e intervenções. In: Diniz DP, Schor N. Qualidade de vida - guias de medicina ambulatorial e hospitalar - UNIFESP Escola Paulista de Medicina. São Paulo: Manole; 2006. p. 1-10.
18. Magaldi CM, Barros ACSD, Magaldi FM, Mantese JC, Pinotti JA. Avaliação da morbidade e funcionalidade do membro superior em mulheres submetidas à linfadenectomia axilar total e biópsia de linfonodo sentinela por câncer de mama. Rev Bras Mastologia. 2005;15(1):9-14.
19. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, et al. Postoperative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95(3):279-93.
20. Organização Mundial da Saúde (OMS)/Organização Panamericana de Saúde (OPAS). CIF classificação internacional de funcionalidade, incapacidade e saúde. São Paulo, SP: Universidade de São Paulo - EDUSP; 2003.
21. Sampaio RF, Mancini MC, Gonçalves GGP, Bittencourt NFN, Miranda AD, Fonseca ST. Aplicação da classificação internacional de funcionalidade, incapacidade e saúde (CIF) na prática clínica do fisioterapeuta. Rev Bras Fisioter. 2005;9(2):129-136.
22. Thomas-Maclean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008;35(1):65-71.
23. Temple LK, Baron R, Cody HS 3rd, Fey JV, Thaler HT, Borgen PI, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002;9(7):654-662.
24. Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ. Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol. 2007;14(5):1653-1661.
25. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer. 2003;89(4):648-652.
26. Paim CA, de Paula Lima ED, Fu MR, de Paula Lima A, Cassali GD. Post lymphadenectomy complications and quality of life among breast cancer patients in Brazil. Cancer Nurs. 2008;31(4):302-309.
27. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93(2):109-119.
28. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37(2):73-91.
29. Helms G, Kühn T, Moser L, Remmel E, Kreienberg R. Soulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection - data from a prospective randomized trial. Eur J Surg Oncol. 2009;35(7):696-701.
30. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006;98(9):599-609.
31. Ohsumi S, Shimozuma K, Kuroi K, Ono M, Imai H. Quality of life of breast cancer patients and types of surgery for breast cancer - current status and unresolved issues. Breast Cancer. 2007; 14(1):66-73.
32. Ferreira BPS, Pimentel MD, Santos LC, Di Flora W, Gobbi H. Morbidade entre a pós-biópsia de linfonodo sentinela e a dissecção axilar no câncer de mama. Rev Assoc Med Bras. 2008;54(6):517-521.
33. Araújo-Soares V, Figueiredo M, Equipa de Dor. Dor: a hidra de sete cabeças. Revista Portuguesa de Psicossomática. 2001;3(2):159-184.
34. Strong J. Assessment of pain perception in clinical practice. Man Ther. 1999;4(4):216-220.
35. Scrimshaw SV, Maher C. Responsiveness of visual analogue and McGill pain scale measures. J Manipulative Physiol Ther. 2001;24(8):501-504.
36. Meijer RS, Rietman JS, Geertzen JH, Bosmans JC, Dijkstra PU. Validity and intra- and interobserver reliability of an indirect volume measurements in patients with upper extremity lymphedema. Lymphology. 2004;37(3):127-133.
37. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003;36(2):84-91.
38. Norkin C, White DJ. Medida do movimento articular: manual de goniometria. 2a ed. Porto Alegre: Artes Médicas; 1997.
39. Orfale AG, Araújo PMP, Ferraz MB, Natour J. Translation into Brazilian Portuguese, cultural adaptation and evaluation of the reliability of the Disabilites of the Arm, Shoulder and Hand Questionnaire. Braz J Med Biol Res. 2005;38(2):293-302.
40. Makluf ASD. Avaliação das propriedades psicométricas dos instrumentos Quality of life questionnaire (EORTC-QLQC30) e Breast cancer module (QLQ-BR23) para avaliação da qualidade de vida em mulheres operadas por câncer de mama [dissertação]. Belo Horizonte (MG): Universidade Federal de Minas Gerais; 2005.
41. Seidl EMF, Zannon CMLC. Qualidade de vida e saúde: aspectos conceituais e metodológicos. Cad Saúde Pública. 2004;20(2):580-588.
42. Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (Disabilities of the Arm, Shoulder, and Hand) [corrected]. Upper Extremity Collaborative Group. Am J Ind Med. 1996;29(6):602-608.